Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report

Centrone, Renato; Bellesso, Marcelo; Bonito, Debora; Dias, Daniela; Santucci, Rodrigo; Aranha, Milton; Alves, Adelson.

Hematol., Transfus. Cell Ther. (Impr.); 42 (4), 2020

Publication year: 2020

Mesilato de Imatinib/uso terapéutico, Leucemia Mielógena Crónica BCR-ABL Positiva/terapia, Cirugía Bariátrica

Fulltext

More related